Hemas_Holdings

Hemas Holdings

Hemas Holdings

Public limited conglomerate in Sri Lanka


Hemas Holdings PLC is a diversified corporate with a focused interest in consumer, healthcare, and mobility. Hemas is a publicly listed company with 5,380 employees.[1]

Quick Facts Company type, Traded as ...

History

In 1948, Hemas started  with simple intent: to empower families to aspire for a better tomorrow. This core belief has informed its growth for over 75 years. Today, Hemas empower families to aspire for a better tomorrow through its focus in Consumer, Healthcare and Mobility. Woven into the socioeconomic fabric of Sri Lanka, Hemas has also expanded operations to Bangladesh.

Operations

Today, Hemas is a publicly quoted company listed on the Colombo Stock Exchange with over 4,000 shareholders and is regarded as one of the most respected and transparent companies in Sri Lanka and Asia's Most Socially Responsible Company.[2]

On 25 June 2020, Kasturi Chellaraja Wilson was appointed as the CEO of Hemas Holdings and will replace Steven Enderby as the CEO with effect from 1 October 2020 as a part of the company's succession plan.[3][4] Kasturi also became the first female group CEO of a public quoted conglomerate in Sri Lanka.[5] She was also appointed as the deputy CEO of Hemas Holdings and will resume her duties as the deputy CEO with effect from 1 July 2020.[6]

On 15 December 2020, Hemas announced they will sell Serendib Hotels to LOLC Group for LKR792 million.[7]


References

  1. "Annual Report 2022/23" (PDF). cse.lk. Hemas Holdings PLC. Retrieved 24 May 2023.
  2. "Hemas wins Asia's Most Socially Responsible Company Award". dailymirror.lk. Retrieved 6 August 2020.
  3. LBO (25 June 2020). "Kasturi Wilson to succeed Steven Enderby as CEO of Hemas". Lanka Business Online. Retrieved 25 June 2020.
  4. "Sri Lanka's Hemas Holdings sells Serendib Hotels to LOLC". EconomyNext. 15 December 2020. Retrieved 16 December 2020.

Share this article:

This article uses material from the Wikipedia article Hemas_Holdings, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.